Altimmune to report second quarter 2023 financial results and provide business update on august 10, 2023

Gaithersburg, md., aug. 03, 2023 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2023 financial results on thursday, august 10, 2023 and will provide a business update.
ALT Ratings Summary
ALT Quant Ranking